Net Worth Advisory Group Cuts Stock Holdings in Koninklijke Philips (NYSE:PHG)

Net Worth Advisory Group lowered its position in Koninklijke Philips (NYSE:PHG) by 4.7% in the 4th quarter, HoldingsChannel.com reports. The firm owned 11,481 shares of the technology company’s stock after selling 571 shares during the period. Net Worth Advisory Group’s holdings in Koninklijke Philips were worth $291,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Dorsey & Whitney Trust CO LLC grew its position in Koninklijke Philips by 3.9% in the 4th quarter. Dorsey & Whitney Trust CO LLC now owns 11,401 shares of the technology company’s stock worth $289,000 after purchasing an additional 427 shares in the last quarter. Legacy Wealth Asset Management LLC boosted its stake in shares of Koninklijke Philips by 1.1% in the 4th quarter. Legacy Wealth Asset Management LLC now owns 51,331 shares of the technology company’s stock worth $1,300,000 after buying an additional 562 shares during the last quarter. First Affirmative Financial Network grew its holdings in shares of Koninklijke Philips by 5.9% in the fourth quarter. First Affirmative Financial Network now owns 10,950 shares of the technology company’s stock valued at $277,000 after acquiring an additional 611 shares in the last quarter. GAMMA Investing LLC increased its position in shares of Koninklijke Philips by 6.3% during the fourth quarter. GAMMA Investing LLC now owns 10,963 shares of the technology company’s stock valued at $278,000 after acquiring an additional 648 shares during the last quarter. Finally, Atria Investments Inc lifted its holdings in Koninklijke Philips by 4.1% during the fourth quarter. Atria Investments Inc now owns 19,009 shares of the technology company’s stock worth $481,000 after acquiring an additional 741 shares during the period. 13.67% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on PHG. UBS Group upgraded Koninklijke Philips from a “neutral” rating to a “buy” rating in a research note on Thursday, February 20th. BNP Paribas upgraded shares of Koninklijke Philips from a “neutral” rating to an “outperform” rating in a research report on Tuesday, February 25th. Finally, StockNews.com raised shares of Koninklijke Philips from a “hold” rating to a “buy” rating in a research report on Saturday. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy”.

Koninklijke Philips Stock Performance

NYSE:PHG opened at $26.75 on Wednesday. The company has a market capitalization of $25.15 billion, a P/E ratio of -31.85, a P/E/G ratio of 0.82 and a beta of 0.78. The business has a fifty day simple moving average of $26.57 and a two-hundred day simple moving average of $27.92. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.23 and a quick ratio of 0.74. Koninklijke Philips has a 1 year low of $19.10 and a 1 year high of $32.91.

Koninklijke Philips (NYSE:PHG) last announced its quarterly earnings data on Wednesday, February 19th. The technology company reported $0.54 earnings per share for the quarter, missing the consensus estimate of $0.55 by ($0.01). The firm had revenue of $5.38 billion during the quarter, compared to analysts’ expectations of $5.10 billion. Koninklijke Philips had a positive return on equity of 10.85% and a negative net margin of 3.88%. On average, analysts expect that Koninklijke Philips will post 1.63 earnings per share for the current year.

Koninklijke Philips Cuts Dividend

The firm also recently declared an annual dividend, which will be paid on Friday, June 6th. Investors of record on Tuesday, May 13th will be paid a dividend of $0.886 per share. This represents a dividend yield of 2.9%. The ex-dividend date is Tuesday, May 13th. Koninklijke Philips’s payout ratio is currently -89.29%.

Koninklijke Philips Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.